Your browser doesn't support javascript.
loading
Mandibular osteonecrosis induced by bisphosphonates in a carrier of chronicle kidney disease / Osteonecrosis mandibular inducida por bifosfonatosen un portador de enfermedad renal crónica
da Silva, Kaohana Thaís; de Oliveira, Greison Rabelo; Garbin Júnior, Eleonor Álvaro; Magro Érnica, Natasha; Griza, Geraldo; Conci, Ricardo Augusto; Seguin, Fabiana.
  • da Silva, Kaohana Thaís; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • de Oliveira, Greison Rabelo; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • Garbin Júnior, Eleonor Álvaro; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • Magro Érnica, Natasha; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • Griza, Geraldo; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • Conci, Ricardo Augusto; Universidade Estadual do Oeste do Paraná. Hospital Universitário do Oeste do Paraná. BR
  • Seguin, Fabiana; Universidade Estadual do Oeste do Paraná. BR
Int. j. med. surg. sci. (Print) ; 4(1): 1119-1125, mar. 2017. ilus
Article in English | LILACS | ID: biblio-1284350
ABSTRACT
he bisphosphonates are synthetic substances of inorganic pyrophosphate that havebeen the basis of treatment of patients with osteolytic diseases, such as multiple myeloma, malignanthypercalcemia, Paget's disease, or patients with bone metastases. Its main pharmacological effect is inhibitionof bone resorption caused by osteoclasts, which have a reduced function. Their adverse effects are infrequentbut include pyrexia, impaired renal function, hypocalcemia, and more recently, maxillo-mandibular ostenecroseinduced bofosfonatos. In this report we describe a clinical case of jaw osteonecrosis induced by bisphosphonatesin patient with chronic kidney disease and the treatment protocol performed
RESUMEN
Los bisfosfonatos son sustancias sintéticas de pirofosfato inorgánico que han sido la base del tratamiento de pacientes con enfermedades osteolíticas, como mieloma múltiple, hipercalcemia maligna, enfermedad de Paget o pacientes con metástasis ósea. Su principal efecto farmacológico es la inhibición dela resorción ósea causada por osteoclastos, que tienen una función reducida. Sus efectos adversos son infrecuentes, pero incluyen pirexia, deterioro de la función renal, hipocalcemia y, más recientemente, indujo inducido por bicosfonatos maxilomandibular. En este informe se describe un caso clínico de osteonecrosis mandibular inducida por bifosfonatos en pacientes con enfermedad renal crónica y el protocolo de trata-miento realizado.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Renal Insufficiency, Chronic / Bisphosphonate-Associated Osteonecrosis of the Jaw Type of study: Practice guideline Limits: Aged / Humans / Male Language: English Journal: Int. j. med. surg. sci. (Print) Journal subject: Surgery / Medicine Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual do Oeste do Paraná/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Renal Insufficiency, Chronic / Bisphosphonate-Associated Osteonecrosis of the Jaw Type of study: Practice guideline Limits: Aged / Humans / Male Language: English Journal: Int. j. med. surg. sci. (Print) Journal subject: Surgery / Medicine Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual do Oeste do Paraná/BR